Editor's choice

Latest Articles

Latest Videos

As well as our peer-reviewed journals, we also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.
  • IEC 2017 Day 4 highlights from Barcelona. View Day 1 highlights here. View Day 2 highlights here. View Day 3 highlights here. Content produced and shared with kind authorisation of the...
  • IEC 2017 Day 3 highlights from Barcelona. View Day 1 highlights here. View Day 2 highlights here. View Day 4 highlights here. Content produced and shared with kind authorisation of the...
  • IEC 2017 Day 2 highlights from Barcelona. View Day 1 highlights here. View Day 3 highlights here. View Day 4 highlights here. Content produced and shared with kind authorisation of the...
  • IEC 2017 Day 1 highlights from Barcelona. View Day 2 highlights here. View Day 3 highlights here. View Day 4 highlights here. Content produced and shared with kind authorisation of the...
  • After a very successful congress in Amsterdam with more than 6000 participants, the EAN Editors-in-Chief, Elena Moro and Tim von Oertzen interviewed the two people responsible for the organisation of...
  • Leading experts including: K Ray Chaudhuri, Peter Goadsby, Stefan Evers and Patrick Vermersch discuss their experiences with European Neurological Review and the touchNEUROLOGY digital platform,...

NEUROLOGY INSIGHTS

The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology:

Insight
No evident disease activity (NEDA) may become the new standard for disease control in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, Reading, UK

Insight
B-cell proliferation following alemtuzumab treatment may create new autoimmunities in patients with multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK

Press Briefing
Eslicarbazepine acetate appears to have no significant detrimental effect on neurocognitive function in children with epilepsy

Catherine Amey, Senior Medical Writer, Touch Medical Media, UK
Jon Shepheard, Neurology Account Director, Touch Medical Media, UK

Lay Summary
Relationship between vitamin D and interferon beta-1b in the treatment of multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK

Lay Summary
Vitamin D deficiency in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK